Summary

The global carrier screening market is expected to grow at a significant rate of around 15% during the forecast period. Genetic screening is a tool used to identify individuals who are at a higher risk of developing a particular disorder or who carry a specific gene for a disorder. It is a type of genetic testing, used to identify changes in an individual’s genetic material, such as their chromosomes, genes, or proteins. Genetic disorders are permanent in nature or have expensive treatment that results in the rising demand for carrier screening tests. Furthermore, the increasing investment in research and development is also an important factor catalyzing the market's growth. For instance, according to the congressional research service, since 2000, total global R&D expenditures have more than tripled in current dollars, from USD 675 billion to USD 2.4 trillion in 2020.

Myriad Genetics, Inc.; Cepheid; Illumina, Inc; Thermo Fisher Scientific; F. Hoffmann-La Roche Ltd; Laboratory Corporation of America Holdings; Otogenetics; T MedGenome; Genentech, Inc; and CENTOGENE N.V. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report
“Amongst Type, expanded carrier screening category to grow with the highest CAGR during the forecast period.”
Based on the type, the market has been categorized into expanded carrier screening and targeted disease carrier screening. Among them, the expanded carrier screening category to grow with the highest CAGR during the forecast period. Expanded carrier screening refers to reproductive genetic carrier screening beyond one’s ethnicity and family history. Due to the ability of the technique to read more than 100 genes at a time and the examination of multiple genetic disorders, the segment is expected to witness fast growth during the forecast period.

“Amongst Medical Conditions, cystic fibrosis segment to grow at a fast rate during the forecast period”
Based on the medical condition, the market has been categorized into cystic fibrosis, Tay Sachs, Gaucher disease, sickle cell disease, spinal muscular atrophy, and others. Among them, the cystic fibrosis segment will grow fast during the forecast period. The increasing prevalence of the disease is the main reason for the rapid growth of the segment. For instance, as per the American Lung Association, there are about 30,000 people with cystic fibrosis in the United States and approximately 70,000 people worldwide.

“Amongst End-users, clinics segment to hold a higher CAGR during the forecast period”
Based on the end-users, the market has been categorized into hospitals, laboratories, clinics, and others. Among them, the clinics segment holds a higher CAGR during the forecast period. The increasing number of private clinicians along with the increasing governmental effort in the development of local clinics for better access to healthcare facilities attributes to the significant growth of the segment in the carrier screening market.

“Asia Pacific to witness the fastest growth in the market”
Asia-Pacific is anticipated to grow at the fastest rate during the forecast period. The major factors such as the presence of emerging economies, frequent product launches, and governmental policies to support child and maternal health responsible for the market growth in the region. For instance, in August 2020, Dr Harsh Vardhan, Union Minister of Health & Family Welfare inaugurated a Thalassemia Screening and Counselling Centre at the Indian Red Cross Society’s National Headquarters Blood Bank.

Reasons to buy this report:
• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
• The report presents a quick review of overall industry performance at one glance.
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
• The study comprehensively covers the market across different segments.
• Deep dive regional level analysis of the industry.

Customization Options:
The global Carrier Screening market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

ページTOPに戻る

Table of Contents